Kobayashi Pharma Shareholders Reject Hong Kong Fund's Proposals

   Osaka, Feb. 19 (Jiji Press)--Kobayashi Pharmaceutical Co. shareholders voted down proposals by Hong Kong-based investment fund Oasis Management Co. at their extraordinary meeting in Osaka on Wednesday.
   Oasis, whose stake in the Japanese maker and seller of over-the-counter drugs and supplements tops 10 pct, proposed that lawyer Yoshio Nakamura and two others be appointed as outside board directors and that the high-profile health damage, including fatal cases, linked to "benikoji" red yeast supplements be reinvestigated under a more independent framework.

(2025/02/19-18:47)